Indivior Pharmaceuticals, Inc. Share Price
Stocks
INDV
US45579U1097
Pharmaceuticals
OTC Markets Traded|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 38.70 USD | -0.31% |
|
+2.35% | +6.61% |
| 04/08 | Indivior Pharmaceuticals, Inc. Enters into Senior Secured Term Loan Facility | CI |
| 04/08 | Indivior Pharmaceuticals, Inc. Proposes Special Cash Dividend | CI |
| Market Cap | 458.13Cr 396.6Cr 370.7Cr 338.8Cr 638.45Cr 44TCr 648.44Cr 4.35TCr 1.71TCr 22TCr 1.72TCr 1.68TCr 73TCr | P/E 2026 * |
10.4x | P/E 2027 * | 9.46x |
|---|---|---|---|---|---|
| Enterprise Value | 463.58Cr 401.32Cr 375.11Cr 342.84Cr 646.05Cr 44TCr 656.15Cr 4.4TCr 1.73TCr 22TCr 1.74TCr 1.7TCr 74TCr | EV / Sales 2026 * |
3.49x | EV / Sales 2027 * | 3.07x |
| Free-Float |
97.98% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Indivior Pharmaceuticals, Inc.
| 1 day | -1.33% | ||
| 1 week | +2.35% | ||
| Current month | -4.40% | ||
| 1 month | -5.56% | ||
| 3 months | -1.52% | ||
| 6 months | +14.32% | ||
| Current year | +6.61% |
| 1 week | 35.76 |  | 39.74 |
| 1 month | 35.76 | | 41.84 |
| Current year | 27.68 | | 42.81 |
| 1 year | 21.83 | | 42.81 |
| 3 years | 7.33 | | 42.81 |
| 5 years | 7.33 | | 42.81 |
| 10 years | 1.75 | | 42.81 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 05/08/26 | Buy | Controller/Auditor | 1,500 | 0.0012% | ||
| 10/07/26 | Sell | Chief Scientific Officer | -18,586 | 0.0152% | ||
| 13/05/26 | Free | Director | 6,518 | 0.0053% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.31% | +2.35% | +71.60% | +65.23% | 458.13Cr | |
| +3.52% | +8.11% | +90.85% | +132.54% | 1,05700Cr | |
| +0.10% | +2.04% | +49.36% | +50.79% | 62TCr | |
| -0.23% | -0.31% | +23.01% | +61.35% | 43TCr | |
| +1.58% | +4.80% | +51.48% | +39.79% | 36TCr | |
| +0.65% | +1.85% | +32.06% | +39.99% | 30TCr | |
| +0.79% | +4.26% | +8.64% | +7.42% | 25TCr | |
| +0.76% | +8.73% | +44.49% | +57.19% | 22TCr | |
| +0.34% | +1.27% | -5.10% | -50.94% | 21TCr | |
| -0.26% | +1.55% | +10.55% | +66.48% | 17TCr | |
| Average | +0.52% | +0.55% | +37.69% | +46.98% | 36.25TCr | |
| Weighted average by Cap. | +1.03% | +1.33% | +49.12% | +66.20% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 132.72Cr 114.9Cr 107.39Cr 98Cr 184.96Cr 13TCr 187.85Cr 1.26TCr 494.16Cr 6.33TCr 498.35Cr 487.48Cr 21TCr | 136.2Cr 117.91Cr 110.21Cr 100.73Cr 189.81Cr 13TCr 192.78Cr 1.29TCr 507.11Cr 6.5TCr 511.42Cr 500.26Cr 22TCr |
| Net income | 47Cr 40Cr 38Cr 35Cr 65Cr 4.45TCr 66Cr 443.12Cr 173.88Cr 2.23TCr 175.35Cr 171.53Cr 7.42TCr | 50Cr 44Cr 41Cr 37Cr 70Cr 4.79TCr 71Cr 476.84Cr 187.11Cr 2.4TCr 188.7Cr 184.58Cr 7.99TCr |
| Net Debt | 5.45Cr 4.72Cr 4.41Cr 4.03Cr 7.6Cr 519.79Cr 7.71Cr 52Cr 20Cr 260.04Cr 20Cr 20Cr 866.06Cr | -40Cr -35Cr -33Cr -30Cr -56Cr -3.85TCr -57Cr -382.77Cr -150.2Cr -1.92TCr -151.47Cr -148.17Cr -6.41TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 11/26/11 | $38.75 | -0.19% | 10,69,388 |
| 07/26/07 | $38.82 | +0.39% | 16,87,043 |
| 06/26/06 | $38.67 | -0.15% | 26,76,314 |
| 05/26/05 | $38.73 | +6.11% | 42,75,247 |
| 04/26/04 | $36.50 | -2.33% | 71,55,095 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- INDV Stock
Select your edition
All financial news and data tailored to specific country editions
